These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7627900)

  • 21. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm.
    Price J; O'Day J
    Aust N Z J Ophthalmol; 1994 Nov; 22(4):255-60. PubMed ID: 7727103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients].
    Ceballos-Baumann AO; Gasser T; Dengler R; Oertel WH
    Nervenarzt; 1990 Oct; 61(10):604-10. PubMed ID: 2274092
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of botulinum toxin in blepharospasm.
    Shorr N; Seiff SR; Kopelman J
    Am J Ophthalmol; 1985 May; 99(5):542-6. PubMed ID: 4003489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with botulinum toxin treatment of facial-cervical dystonias and hemifacial spasm].
    Erbguth F; Claus D; Neundörfer B
    Nervenarzt; 1990 Oct; 61(10):611-4. PubMed ID: 2274093
    [No Abstract]   [Full Text] [Related]  

  • 26. Botulinum toxin in the treatment of facial dyskinesias.
    Chong PN; Ong B; Chan R
    Ann Acad Med Singap; 1991 Mar; 20(2):223-7. PubMed ID: 1883180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of blepharospasm and facial hemispasm with botulinum toxin. Apropos of 58 injections in 22 patients].
    Elbaz D
    Ann Otolaryngol Chir Cervicofac; 1994; 111(3):141-4. PubMed ID: 7840486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias.
    Mauriello JA; Coniaris H; Haupt EJ
    Ophthalmology; 1987 Aug; 94(8):976-9. PubMed ID: 3658375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of botulinum toxin in ophthalmology].
    Nemet P; Stolovitch C
    Harefuah; 1989 Jul; 117(1-2):9-10. PubMed ID: 2792958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm.
    Ainsworth JR; Kraft SP
    Ophthalmology; 1995 Dec; 102(12):2036-40. PubMed ID: 9098314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm.
    Wirtschafter JD
    Ophthalmology; 1991 Mar; 98(3):357-66. PubMed ID: 2023757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurology quiz. Idiopathic hemifacial spasm.
    Horne M
    Aust Fam Physician; 1994 Jul; 23(7):1366-8. PubMed ID: 8060285
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of facial spasm with botulin A toxin].
    Adenis JP; Smolik I; Maes S
    J Fr Ophtalmol; 1990; 13(5):259-64. PubMed ID: 2258549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of facial hemispasms and median facial spasms by injection of botulinum toxin. Initial results].
    Saraux H; Laroche L; Pelosse B
    Bull Soc Ophtalmol Fr; 1987 Dec; 87(12):1361-2. PubMed ID: 3453298
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic Approach to Botulinum Injections for Hemifacial Spasm, Synkinesis and Blepharospasm.
    Yahalom G; Janah A; Rajz G; Eichel R
    Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin: preferred treatment for hemifacial spasm.
    Flanders M; Chin D; Boghen D
    Eur Neurol; 1993; 33(4):316-9. PubMed ID: 8348919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.